Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Shared genetic structure between COVID-19 and migraine: insights from large-scale genome-wide cross-trait analysis

Submitted by Anna Hakala on Tue, 03/10/2026 - 10:39
  • Read more about Shared genetic structure between COVID-19 and migraine: insights from large-scale genome-wide cross-trait analysis

Direct Oral Anticoagulant Protein Targets and Risk of Cerebral Venous Thrombosis: A Mendelian Randomization Study

Submitted by Anna Hakala on Tue, 03/10/2026 - 10:31
  • Read more about Direct Oral Anticoagulant Protein Targets and Risk of Cerebral Venous Thrombosis: A Mendelian Randomization Study

Corrigendum to "Genetic risk factors for pneumonia differ by patient subgroup" [eBioMedicine 124 (2026) 106136] DOI: 10.1016/j.ebiom.2026.106136

Submitted by Anna Hakala on Tue, 03/10/2026 - 10:30
  • Read more about Corrigendum to "Genetic risk factors for pneumonia differ by patient subgroup" [eBioMedicine 124 (2026) 106136] DOI: 10.1016/j.ebiom.2026.106136

Mitochondrial Gene Networks in Opioid Use Disorder: Multi-omic Evidence for Pathway-Specific Risk and Resilience

Submitted by Anna Hakala on Thu, 03/05/2026 - 16:53
  • Read more about Mitochondrial Gene Networks in Opioid Use Disorder: Multi-omic Evidence for Pathway-Specific Risk and Resilience

Immune cell of CD127 on CD28+ CD45RA+ CD8br-Regulated ZDHHC20 Prevents the Progression of Atrial Fibrillation

Submitted by Anna Hakala on Thu, 03/05/2026 - 16:37
  • Read more about Immune cell of CD127 on CD28+ CD45RA+ CD8br-Regulated ZDHHC20 Prevents the Progression of Atrial Fibrillation

Structural variants contribute substantially to complex trait heritability

Submitted by Anna Hakala on Wed, 03/04/2026 - 12:14
  • Read more about Structural variants contribute substantially to complex trait heritability

Defining and Modeling Human Interleukin-34 Deficiency

Submitted by Anna Hakala on Wed, 03/04/2026 - 12:13
  • Read more about Defining and Modeling Human Interleukin-34 Deficiency

Impact of proteogenomic evidence on clinical success

Submitted by Anna Hakala on Wed, 03/04/2026 - 12:10
  • Read more about Impact of proteogenomic evidence on clinical success

Triglyceride-rich lipoproteins, low-density lipoproteins, and risk of abdominal aortic aneurysm

Submitted by Anna Hakala on Wed, 03/04/2026 - 12:08
  • Read more about Triglyceride-rich lipoproteins, low-density lipoproteins, and risk of abdominal aortic aneurysm

Development and validation of polygenic risk profiles of schizophrenia

Submitted by Anna Hakala on Wed, 03/04/2026 - 11:58
  • Read more about Development and validation of polygenic risk profiles of schizophrenia

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Current page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement